Overview

Pharmacokinetic Study Of EPZICOM Tablet

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study was designed to explore the drug levels in the blood in Japanese HIV-infected patients taking EPZICOM tablet at least for 2 weeks prior to administration of the study drug. Pharmacokinetics after administration of EPZICOM tablet will be investigated in a total of 8 subjects.
Phase:
Phase 4
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Abacavir
Dideoxynucleosides
Lamivudine